Publications by authors named "Paula M Calvert"

Claim this Profile
S
Social supports in patients with cancer attending an Irish cancer center: a cross-sectional study.
Caitriona Goggin, Yasser Ged, Dara Bracken-Clarke, Michelle Hannan, Flordeliza Calacsan, Paula M Calvert

Oncologist· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Niraparib Population Pharmacokinetics and Exposure-Response Relationships in Patients With Newly Diagnosed Advanced Ovarian Cancer.
Bradley J Monk, Ignacio Romero, Whitney Graybill, Cristina Churruca, David M O'Malley, Paula M Calvert

Clin Ther· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective evaluation of the tolerability and efficacy of niraparib dosing based on baseline body weight and platelet count: Results from the PRIMA/ENGOT-OV26/GOG-3012 trial.
Mansoor R Mirza, Antonio González-Martín, Whitney S Graybill, David M O'Malley, Lydia Gaba, Paula M Calvert

Cancer· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prognostic value of the derived neutrophil-to-lymphocyte ratio (dNLR) in patients treated with immune checkpoint inhibitors.
William J Mullally, John Greene, Emmet J Jordan, Anne M Horgan, Miriam O'Connor, Paula M Calvert

Ir J Med Sci· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of niraparib by time of surgery and postoperative residual disease status: A post hoc analysis of patients in the PRIMA/ENGOT-OV26/GOG-3012 study.
Roisin E O'Cearbhaill, Jose-Alejandro Pérez-Fidalgo, Bradley J Monk, Ignacio Tusquets, Colleen McCormick, Paula M Calvert

Gynecol Oncol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pilot study of bevacizumab in combination with docetaxel and cyclophosphamide as adjuvant treatment for patients with early stage HER-2 negative breast cancer, including analysis of candidate circulating markers of cardiac toxicity: ICORG 08-10 trial.
Giuseppe Gullo, Alex J Eustace, Alexandra Canonici, Denis M Collins, Michael J Kennedy, Paula M Calvert

Ther Adv Med Oncol· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The genetics of colorectal cancer.
Paula M Calvert, Harold Frucht

Ann Intern Med· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis